16:41 EST TriSalus Life Sciences (TLSI) files $150M mixed securities shelf
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSI:
- TriSalus Life Sciences reports Q3 EPS (96c) vs (12c) last year
- TriSalus Life Sciences: Expanding Market Opportunities and Innovative Technology Justify Buy Rating
- Is TLSI a Buy, Before Earnings?
- TriSalus Life Sciences: Strategic Positioning and Product Pipeline Drive Buy Rating Amid Long-Term Growth Potential